Over the past 20 years, Weigao has adhered to the factory building policy of "exploitation, innovation, truth-seeking and consolidation", using technological innovation as the driving force and scientific management as the backing, promoting the sustainable, rapid and healthy development of the enterprise. The company was the first to develop disposable infusion consumables, surgical sutures, implantable medical catheters, cardiac stents, indwelling needles and various special-shaped needles, blood purification series products, orthopedic series products, mechatronics medical devices, It has established a large-scale medical supplies industrial park, orthopedic materials industrial park, medical science and technology industrial park, and aerospace electronic product production base, including therapeutic injections, biological diagnostic reagents, artificial plasma and other medical devices and drugs, and has now become the largest in China. manufacturer of single-use medical devices.

Weigao Group adheres to the development strategy of "people-oriented, science and technology first", improves the scientific management model, and improves the management system. The company is the first in the industry to introduce and use advanced management software such as ERP and KPI. Its products have passed CE, ISO9001, ISO13485, 3C and other certifications, and some products have passed the US FDA marketing authorization. The company's testing center is accredited by the National Laboratory Accreditation Board. The persistent pursuit of science and technology has given Weigao Group room for survival and development. The company has been designated by the Ministry of Science and Technology and other ministries as a "Key High-tech Enterprise of the National Torch Plan", a "National High-tech Research and Development (863) Plan Achievements Industrialization Base", and a "National Enterprise Technology Center", and has established a corporate postdoctoral workstation. The company actively carries out industry, academia and research cooperation, and cooperates with Changchun Institute of Applied Chemistry of the Chinese Academy of Sciences, Dalian Institute of Chemical Physics of the Chinese Academy of Sciences, Shenyang Institute of Metal Research of the Chinese Academy of Sciences, Third Military Medical University, 301 Hospital, Harbin Institute of Technology (Weihai) and other scientific research institutes and colleges. We have worked closely together and hired 10 academicians from the two academies as consultants. Relying on their talents and scientific research strength, we have established nine Weigao Group R&D centers in remote locations. Based on the commanding heights of the industry, we have digested and absorbed international cutting-edge technologies and developed high-tech products with independent intellectual property rights. product. The company has more than 60 products that have reached the advanced level at home and abroad, and many products have filled domestic gaps. 20 products have been selected into various national projects such as the National 863 Program, the National Key Torch Program, the National High-tech Industry Demonstration Project, and the National Key New Products. Projects, including drug-coated stent systems, prefilled syringes, orthopedic implant materials and other products, have broken the monopoly of foreign companies on the Chinese market.

Weigao Group unremittingly implements the famous brand strategy and cultivates well-known brands. The "Jierui" trademark was recognized as "China's Well-known Trademark", "Jierui Brand Disposable Sterile Infusion Medical Device" was awarded the title of "China Famous Brand Product", and the "Jierui" brand was rated as one of China's top brands by the China Brand Research Institute The first brand of medical equipment. The company has established more than 100 sales offices in more than 30 provinces, municipalities, and autonomous regions across the country, and has established long-term and stable relationships with more than 7,000 hospitals, more than 400 blood stations, and more than 1,800 commercial companies across the country. The company's products not only sell well in more than 30 domestic provinces, municipalities, and autonomous regions, but are also directly exported to more than 50 countries and regions such as the United States, the European Union, Russia, South Africa, and Brazil.

Weigao Group will consistently adhere to the scientific outlook on development, with the purpose of "carrying the messengers in white to create a healthy future", and vigorously promote the industrial structure and product structure with disposable medical devices and drugs as the leading role. , adjust the institutional structure, realize the internationalization of capital, technology and management, and strive to become the most competitive, Asia-leading and most respected medical device and pharmaceutical company in the world, and make contributions to promote the development of my country's medical industry and improve people's health. new contribution.

Weigao Group